Basic health screening should be conducted to check for conditions that make GLP-1 medications unsafe, such as certain thyroid conditions, pancreas problems, or severe digestive issues
Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
Its best to consult with a healthcare professional before taking semaglutide if you have any preexisting conditions
If you lose 10% or more of your body weight while taking levothyroxine at a dose calibrated for your higher weight, you may become relatively over-medicated
Preparing for a GLP-1 injection is simple, but a few steps can help ensure a smooth and comfortable experience, especially during the early phases of treatment: Your first session will also include clear guidance on how to administer injections (if applicable), what to expect in the coming days, and how to reach the care team for any concerns
This tension is also fueling debates about responsible prescribing and pharmaceutical advertising
.webp)
